Back
Protagonist Therapeutics Stock Predictions
Sponsored
PTGX
Sponsored
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
45
PTGX
Protagonist Therapeutics
Last Price:
43.12
Seasonality Move:
12.96%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!Protagonist Therapeutics Stock Forecast
- Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 40.7% based on the past 8 years of stock performance.
- Protagonist Therapeutics has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
-
Is Protagonist Therapeutics Stock Undervalued?
The current Protagonist Therapeutics [PTGX] share price is $46.50. The Score for PTGX is 45, which is 10% below its historic median score of 50, and infers higher risk than normal. - PTGX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Protagonist Therapeutics Stock Go Up Next Year?
- Over the next 52 weeks, Protagonist Therapeutics has on average historically risen by 40.7% based on the past 8 years of stock performance.
Protagonist Therapeutics Stock Rating
Sell
45
Protagonist Therapeutics (PTGX)
is a Sell
Is Protagonist Therapeutics overpriced?
- Protagonist Therapeutics has risen higher in 5 of those 8 years over the subsequent 52-week period, corresponding to a historical accuracy of 62.5%
Protagonist Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
protagonist-inc.com
52-Week Data
52-Week High:
48.89
52-Week Low:
15.05
Prediction Charts
Market Cap:
2.77B
Price in USD:
46.50
Volume:
558.13K
Beta:
2.10
Technical Analysis
SMA50:
45.52
SMA100:
41.49
SMA200:
35.08
52-Wk Change:
200.19%
Stock Predictions
-
Is Protagonist Therapeutics stock public?
Yes, Protagonist Therapeutics is a publicly traded company. -
What is the Protagonist Therapeutics stock quote today?
The Protagonist Therapeutics stock price is 46.50 USD today. -
How to buy Protagonist Therapeutics stock online?
You can buy Protagonist Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-23 | 46.31 | 46.59 | 46.68 | 45.48 |
Oct-24 | 46.71 | 46.95 | 47.30 | 46.34 |
Oct-25 | 47.30 | 47.26 | 47.95 | 46.84 |
Oct-28 | 47.69 | 48.20 | 48.89 | 47.35 |
Oct-29 | 47.95 | 48.42 | 48.62 | 47.58 |
Oct-30 | 48.01 | 47.62 | 48.30 | 47.44 |
Oct-31 | 47.18 | 45.83 | 47.32 | 45.65 |
Nov-1 | 46.11 | 46.76 | 47.02 | 45.99 |
Nov-4 | 46.30 | 46.76 | 47.76 | 45.37 |
Nov-5 | 47.15 | 45.90 | 47.31 | 43.86 |
Nov-6 | 48.16 | 47.57 | 48.67 | 46.39 |
Nov-7 | 47.43 | 47.61 | 48.69 | 46.53 |
Nov-8 | 48.86 | 46.23 | 48.86 | 45.23 |
Nov-11 | 46.90 | 46.50 | 48.35 | 46.43 |
Protagonist Therapeutics Earnings
Protagonist Therapeutics Earnings Report: Per Share Protagonist Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.
Protagonist Therapeutics Forecast Revenue Growth
Protagonist Therapeutics Stock Analysis: Historical quarterly revenues per share for Protagonist Therapeutics and historical quarterly revenue growth:
- Analysts estimate an earnings increase this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.24 per share, and a decrease next year of $5.00 per share.
* Protagonist Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.